SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-15-008425
Filing Date
2015-06-17
Accepted
2015-06-17 19:47:58
Documents
1
Period of Report
2015-06-16

Document Format Files

Seq Description Document Type Size
1 rrd425737.html 3  
1 rrd425737.xml 3 4168
  Complete submission text file 0001181431-15-008425.txt   5710
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address
Viswanathan Ravi (Reporting) CIK: 0001479386 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22873 | Film No.: 15938362